← Latest Filings
A

Azamian Bobak R.

President/CEO and Board Chair

Open-market buys
0
$0 total
Open-market sells
10
$5.2M total
Tracking since
Dec 2025
Open-market sale — $265K
Open-market sale — $641K
Open-market trades from the last two years.
827,991 Common Stock in TARS
Held indirectly (By the Bobak Azamian Living Trust established April 16, 2018) · as of 2026-09-04
96,723 Stock Option (right to buy) in TARS
Held directly · as of 2026-03-05
Tarsus Pharmaceuticals, Inc.
CIK 0001819790